Advertisement
Hong Kong
OpinionLetters

Letters | How Hong Kong’s healthcare ‘Davids’ can compete on the world stage

  • Readers urge Hong Kong healthcare companies to grasp the opportunities provided by the Belt and Road Initiative, and discuss how the government can help boost blood donation

Reading Time:2 minutes
Why you can trust SCMP
1
Expenditure on healthcare in Hong Kong grew at an annual rate of 5.6 per cent from 1990 to 2020: Shutterstock
Letters
Feel strongly about these letters, or any other aspects of the news? Share your views by emailing us your Letter to the Editor at [email protected] or filling in this Google form. Submissions should not exceed 400 words, and must include your full name and address, plus a phone number for verification.

David’s epic victory over Goliath has enlightened many that even an underdog can have its day when fighting more sizeable opponents. The same applies to healthcare companies in Hong Kong when they step into a global healthcare field that already has a number of giants.

The Hong Kong Productivity Council recently released a research report on the development of Hong Kong’s healthcare industry. Most healthcare companies in the city are “Davids” when it comes to business turnover and staff numbers.

Advertisement

In terms of business volume, 60 per cent of researched Hong Kong companies have an annual turnover of US$5 million or less, and only 20 per cent of them recorded more than US$10 million. As for staff size, 43 per cent of the researched Hong Kong companies have manpower of 10 people or fewer. Only 8 per cent of them have a staff size that ranges from 101 to 1,000.

Healthcare is a thriving industry with a bright future. Expenditure on healthcare in Hong Kong grew at an annual rate of 5.6 per cent from 1990 to 2020. In 2020, healthcare-related expenditures accounted for 7.1 per cent of mainland China’s gross domestic product, while the global biotech industry raised as much as US$70.9 billion in the same year. Fortunately, Hong Kong has a strong foundation in the healthcare sector, and the city is the largest biotech IPO centre in Asia and the second largest in the world.
Advertisement
According to the Productivity Council study, 51 per cent and 55 per cent of Hong Kong healthcare businesses are engaged in production and trading respectively. Meanwhile, the figures for those in the Greater Bay Area are 77 per cent and 11 per cent. As such, the former should take better advantage of the latter in terms of production.
Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x